CVS - CVS Health Corporation
| Previous Close | 66.60 |
| Open | 66.25 |
| Bid | 65.71 x 100 |
| Ask | 68.74 x 100 |
| Day's Range | 66.18 - 68.09 |
| 52 Week Range | 60.14 - 84.00 |
| Volume | 7,379,252 |
| Avg. Volume | 8,683,196 |
| Market Cap | 68.849B |
| Beta | 0.92 |
| PE Ratio (TTM) | 10.51 |
| EPS (TTM) | 6.44 |
| Earnings Date | May 2, 2018 |
| Forward Dividend & Yield | 2.00 (3.15%) |
| Ex-Dividend Date | 2018-04-20 |
| 1y Target Est | 88.57 |
Market Realist•22 hours agoUNH Stock Rose ~3.5% on Stellar 1Q18 Performance: What’s Next?
UnitedHealth Group (UNH) stock recorded a rise of ~3.5% on April 17, as the company posted strong 1Q18 results. On April 19, UNH stock closed at $235.76 per share. The company beat analysts’ estimates for its sales, earnings, and profit estimates and raised its fiscal 2018 outlook. UNH stock is trading higher than its 50-day moving average of $224.87 and its 200-day moving average of $220.79.
- PR Newswire•23 hours ago
CVS Health Releases 11th Annual Corporate Social Responsibility Report
WOONSOCKET, R.I., April 25, 2018 /PRNewswire/ -- CVS Health (CVS) today released its 11th annual Corporate Social Responsibility (CSR) Report, detailing its latest efforts to shape the future of health care, reduce environmental impacts and exemplify corporate leadership in fulfilling the company's purpose of helping people on their path to better health. Among the company's key CSR initiatives in 2017 were an enterprise response to combatting the opioid crisis, the development of a carbon emissions reduction target in line with climate science, and a rapid and robust response to a series of natural disasters that impacted CVS Health operations, colleagues and communities.
Market Realist•23 hours agoRecommendations for UNH Stock after Its 1Q18 Results: All ‘Buy’
UnitedHealth Group (UNH), the world’s largest healthcare company by revenue, reported its fiscal 1Q18 earnings results on April 17, 2018. The company’s sales and earnings results exceeded Wall Street analysts’ estimates.
- Simply Wall St.•2 days ago
Should You Buy CVS Health Corporation (NYSE:CVS)?
Today we’re going to take a look at the well-established CVS Health Corporation (NYSE:CVS). The company’s stock saw significant share price volatility over the past couple of months on theRead More...
- Reuters•2 days ago
Glenview's Robbins says talk of Amazon's entering pharma is overblown
Glenview Capital Management Chief Executive Larry Robbins said on Monday at the Sohn Investment Conference in New York that he still likes a trio of stocks he already owns, citing CVS Health Corp (CVS.N), McKesson Corp (MCK.N) and Express Scripts Holdings (ESRX.O). Amazon has not made significant hires in the pharmacy business and does not have the licenses needed to enter the business, Robbins said. Amazon's entry into the business of selling medications, is "neither imminent, assured, nor likely to succeed," he said.
- Yahoo Finance•2 days ago
Hedge fund billionaire explains why Amazon won't get into pharma
Amazon hasn't obtained pharamcy licenses to sell pills.
- Zacks•2 days ago
Factors Setting Stage for CVS Health's (CVS) Q1 Earnings
CVS Health (CVS) expects robust 2018 PBM selling season and strong Pharmacy Services segment to drive earnings in Q1.
- Reuters•3 days ago
Glenview's Robbins says talk of Amazon's entering pharma is overblown
Glenview Capital Management Chief Executive Larry Robbins said on Monday at the Sohn Investment Conference in New York that he still likes a trio of stocks he already owns, citing CVS Health Corp, McKesson Corp and Express Scripts Holdings. Amazon has not made significant hires in the pharmacy business and does not have the licenses needed to enter the business, Robbins said. Amazon's entry into the business of selling medications, is "neither imminent, assured, nor likely to succeed," he said.
- CNBC•3 days ago
You can get rid of your unused medications at these drugstores
If you have leftover pain pills or other prescription drugs, you should get rid of them. Drugstore chains Walgreens and CVS Health are adding kiosks in some of their stores to make it easier.
- ACCESSWIRE•3 days ago
Today's Research Reports on Trending Tickers: Eleven Biotherapeutics and CVS Health
NEW YORK, NY / ACCESSWIRE / April 23, 2018 / U.S. markets dropped Friday as positive corporate earnings were offset by losses from the technology and consumer staples sectors. The yield on the 10-year ...
- Motley Fool•4 days ago
Better Buy: CVS Health Corporation vs. Express Scripts
Both companies are in the thick of big acquisition deals. But which is the better stock to buy now?
- American City Business Journals•5 days ago
Longs Drugs opening Makaha store, preps to start on new Nanakuli shopping center
The 18,130-square-foot Longs Drugs store is opening this weekend in the old Cornet building at the Makaha Gateway center at the corner of Farrington Highway and Makaha Valley Road.
- Forbes•6 days ago
Shift To Obamacare Bronze Plans Boosts CVS, Walgreens And Walmart Clinics
Ken Werner gives his health information to nurse practitioner Yana Dymarskiy before getting a flu vaccine at a Walgreens healthcare clinic on September 19, 2013 in Wheeling, Illinois. Retail clinics operated by CVS Health, Walmart and Walgreens Boots Alliance could see an uptick in customers thanks to a shift by Americans into Obamacare’s higher deductible bronze plans, a new Robert Wood Johnson Foundation analysis indicates.
- PR Newswire•6 days ago
CVS Health Corporation To Hold First Quarter 2018 Conference Call
WOONSOCKET, R.I., April 20, 2018 /PRNewswire/ -- CVS Health Corporation (CVS) will be holding a conference call on Wednesday, May 2, 2018, at 8:30 a.m. (ET) with analysts and investors to discuss its first quarter financial results. An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. This webcast will be archived and available on the website for a one-year period following the conference call.
- PR Newswire•6 days ago
CVS Pharmacy Offering Hepatitis A Vaccine to Kentuckians Following an Increase in Confirmed Cases of the Virus
WOONSOCKET, R.I., April 20, 2018 /PRNewswire/ -- CVS Pharmacy is encouraging unvaccinated Kentucky residents to receive the Hepatitis A vaccine following an increase in confirmed cases of the virus. According to the Kentucky Department for Public Health, more than 300 Hepatitis A cases have been confirmed across the state since 2017. All 79 CVS Pharmacy locations in Kentucky, including the nine CVS Pharmacy in Target locations, have the Hepatitis A vaccine available for people who have not yet been vaccinated.
- PR Newswire•7 days ago
CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Ohio to Help Combat Opioid Abuse
Company also announces $85,000 grant to Neighborhood Family Practice in Cleveland to support addiction recovery WOONSOCKET, R.I. , April 19, 2018 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today ...
- PR Newswire•7 days ago
CVS Pharmacy Launches First Campaign Featuring Unaltered Beauty Imagery
Beauty in Real Life is the first campaign to adapt new standards for post-production photo alterations and will unveil the first images to feature the "CVS Beauty Mark," a watermark designed to highlight imagery that has not been materially altered.
- Forbes•7 days ago
For Now, Hospitals Hang On Despite CVS, Optum And Walmart Threats
Walmart Global eCommerce office, also known as WalmartLabs, in Sunnyvale, California on February 25, 2018. The finances of hospitals and health systems are performing surprisingly well in the face of unprecedented competition coming their way from rapidly consolidating providers of outpatient care, according to a new Fitch Ratings analysis. The Fitch report provides a snapshot of the financial health of not-for-profit hospitals, showing upgrades have outpaced downgrades, “27% to 13%” since January for hospitals the agency had placed on a “Rating Watch.” Fitch looked at a cross section of more than 50 hospitals including small independent facilities to larger multi-hospital systems.
- ACCESSWIRE•7 days ago
EX-Dividend Schedule: CVS Health Has a Dividend Yield of 3.03%; Will Trade Ex-Dividend on April 20, 2018
LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors has a free review on CVS Health Corp. (NYSE: CVS) following the Company's announcement that it will begin trading ex-dividend on April 20, 2018. Active-Investors has initiated due-diligence on this dividend stock. If your portfolio includes dividend stocks, you have come to the right place for timely information.
- PR Newswire•8 days ago
Phoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans' Access to Health Care
To date, nearly 1,500 veterans have received timely treatment for minor illnesses and injuries at Phoenix-area MinuteClinic locations PHOENIX , April 18, 2018 /PRNewswire/ -- CVS Health (NYSE: CVS), ...
- American City Business Journals•8 days ago
Aetna to hire 250 as part of 'innovation hub' expansion in Wellesley
Health insurance giant Aetna is expanding its presence in the Bay State, months after choosing New York over Boston to relocate its headquarters.
- MarketWatch•9 days ago
Aetna to reorganize ahead of CVS deal
Aetna Inc. said Tuesday afternoon it would reorganize its business units ahead of its expected acquisition by CVS Health Corp. Aetna said it would break its business down into a health-care segment and ...
- Moody's•9 days ago
Moody's: Healthcare Quarterly looks at credit impact of planned mergers in US healthcare
In its latest issue of Healthcare Quarterly, Moody's Investors Service examines how planned mergers between health insurers and other healthcare companies, as well as potential new entrants to the US healthcare ...
- Investopedia•9 days ago
Pharmacy Stocks Rise on News Amazon is Backing Off
Pharmacy stocks got a lift in trading Monday after CNBC reported Amazon is backing off of selling drugs to hospitals.
- Market Realist•9 days ago
Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18
Rite Aid (RAD) reported its fiscal 4Q18 results after the market closed on Thursday, April 12, 2018. Its top line fell 8.6% YoY (year-over-year) to $5.4 billion, missing the average consensus expectation by $180 million.
